Skip to main content
SpringerLink
Log in

Acute Kidney Injury in Oncological Disorders and Tumor Lysis Syndrome

  • Chapter
  • First Online:
Management of Acute Kidney Problems

  • 2500 Accesses

Abstract

Acute kidney injury (AKI) is a serious complication in cancer patients Multiple causes such as metabolic disturbances, tumor lysis syndrome, renal infiltration by malignant cells, sepsis, or drug-induced toxicity may lead to AKI in cancer patients In some cases, cancer treatment is the main cause of AKI

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Benoit DD, Depuydt PO, Vandewoude KH, Offner FC, Boterberg T, De Cock CA, Noens LA, Janssens AM, Decruyenaere JM: Outcome in critically ill medical patients treated with renal replacement therapy for Acute Kidney Injury: comparison between patients with and those without haematological malignancies. Nephrol Dial Transplant 2005; 20:552–558.

    Article  PubMed  Google Scholar 

  2. Darmon M, Thiery G, Ciroldi M, de Miranda S, Galicier L, Raffoux E, Le Gall JR, Schlemmer B, Azoulay E: Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33:2488–2493.

    Article  PubMed  Google Scholar 

  3. Bagshaw SM, Laupland KB, Doig CJ, Mortis G, Fick GH, Mucenski M, Godinez-Luna T, Svenson LW, Rosenal T: Prognosis for long-term survival and renal recovery in ­critically ill patients with severe Acute Kidney Injury: a population-based study. Crit Care 2005; 9:R700–R709.

    Article  PubMed  Google Scholar 

  4. Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001; 12:1164–1172.

    CAS  PubMed  Google Scholar 

  5. Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, et al. Toxic acute tubular necrosis following ­treatment with zoledronate (Zometa). Kidney Int. 2003; 64:281–289.

    Article  CAS  PubMed  Google Scholar 

  6. Quesada JR, Talpaz M, Rios A, Kurzrock R, Gutterman JU. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol. 1986; 4:234–243.

    CAS  PubMed  Google Scholar 

  7. Zuber J, Martinez F, Droz D, Oksenhendler E, Legendre C. Alpha-interferon-associated thrombotic microangiopathy: a clinicopathologic study of 8 patients and review of the literature. Medicine (Baltimore). 2002; 81:321–331.

    Article  CAS  Google Scholar 

  8. Cantrell JE, Jr., Phillips TM, Schein PS. Carcinomaassociated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol. 1985; 3:723–734.

    PubMed  Google Scholar 

  9. Valavaara R, Nordman E. Renal complications of mitomycin C therapy with special reference to the total dose. Cancer. 1985; 55:47–50.

    Article  CAS  PubMed  Google Scholar 

  10. Fung MC, Storniolo AM, Nguyen B, Arning M, Brookfield W, Vigil J. A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer. 1999; 85:2023–2032.

    CAS  PubMed  Google Scholar 

  11. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003; 23:460–464.

    Article  CAS  PubMed  Google Scholar 

  12. Schuchter LM, Hensley ML, Meropol NJ, Winer EP, American Society of Clinical Oncology Chemotherapy and Radiotherapy Expert Panel: 2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2002; 20:2895–2903.

    Article  PubMed  Google Scholar 

  13. Arany I, Safirstein RL: Cisplatin nephrotoxicity. Semin Nephrol 2003; 23:460–464.

    Article  CAS  PubMed  Google Scholar 

  14. Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S, Bacci G, Craft AW, Adamson PC: High-dose methotrexate- induced nephrotoxicity in patients with osteosarcoma. Cancer 2004; 100:2222–2232.

    Article  CAS  PubMed  Google Scholar 

  15. Relling MV, Stapleton FB, Ochs J, Jones DP, Meyer W, Wainer IW, et al. Removal of methotrexate, leucovorin, and their metabolites by combined hemodialysis and hemoperfusion. Cancer. 1988; 62:884–888.

    Article  CAS  PubMed  Google Scholar 

  16. Wall SM, Johansen MJ, Molony DA, DuBose TD, Jr., Jaffe N, Madden T. Effective clearance of methotrexate using high-flux hemodialysis membranes. Am J Kidney Dis. 1996; 28: 846–854.

    Article  CAS  PubMed  Google Scholar 

  17. Buchen S, Ngampolo D, Melton RG, Hasan C, Zoubek A, Henze G, Bode U, Fleischhack G: Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure. Br J Cancer 2005; 92:480–487.

    CAS  PubMed  Google Scholar 

  18. Suarez A, McDowell H, Niaudet P, Comoy E, Flamant F: Longterm follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report. J Clin Oncol 1991; 9:2177–2182.

    CAS  PubMed  Google Scholar 

  19. Andreoli SP, Clark JH, Mcguire WA, Bergstein JM. Purine excretion during tumour lysis in children with acute ­lymphocytic leukaemia receiving allopurinol: relationship to Acute Kidney Injury. J Pediatr. 1986; 109:292–298.

    Article  CAS  PubMed  Google Scholar 

  20. Brogard JM, Coumaros D, Franckhauser J, Stahl A, Stahl J. Enzymatic uricolysis: a study of the effect of a fungal urateoxydase. Rev Eur Etud Clin Biol. 1972; 17:890–895.

    CAS  PubMed  Google Scholar 

  21. Mahmoud HH, Leverger G, Patte C, Harvey E, Lascombes F. Advances in the management of malignancy-associated hyperuricaemia. Br J Cancer. 1998; 77:18–20.

    PubMed  Google Scholar 

  22. Verdecchia P, Schillaci G, Reboldi GP, Santeusanio F, Porcellati C, Brunetti P. Relation between serum uric acid and risk of cardiovascular disease in essential ­hyper­tension: the PIUMA Study. Hypertension. 2000; 36:1072–1078.

    CAS  PubMed  Google Scholar 

  23. Johnson WJ, Kyle RA, Pineda AA, O’Brien PC, Holley KE. Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med. 1990; 150:863–869.

    CAS  Google Scholar 

  24. Alexanian R, Barlogie B, Dixon D. Renal failure in multiple myeloma. Arch Intern Med. 1990; 150:1693–1695.

    Article  CAS  PubMed  Google Scholar 

  25. Reiter E, Kalhs P, Keil F, Rabitsch W, Gisslinger H, Mayer G, et al. Effect of high-dose melphalan and peripheral blood stem cell transplantation on renal function in patients with multiple myeloma and renal insufficiency: a case report and review of the literature. Ann Hematol. 1999; 78:189–191.

    Article  CAS  PubMed  Google Scholar 

  26. Smith DM, Weisenburger DD, Bierman P, Kessinger A, Vaughan WP, Armitage JO. Acute Kidney Injury associated with autologous bone marrow transplantation. Bone Marrow Transplant. 1987; 2:195–210.

    CAS  PubMed  Google Scholar 

  27. Kennedy MS, Deeg HJ, Siegel M, Crowley JJ, Storb R, Thomas ED. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation. Transplantation. 1983; 35:211–215.

    Article  CAS  PubMed  Google Scholar 

  28. McDonald GB, Hinds MS, Fisher LD, Schoch HG, Wolford JL, Banaji M, Hardin BJ, Shulman HM, Clift RA: Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 1993; 118:255–267.

    CAS  PubMed  Google Scholar 

  29. Mori K, Yoshihara T, Nishimura Y, Uchida M, Katsura K, Kawase Y, Hatano I, Ishida H, Chiyonobu T, Kasubuchi Y, et al.: AKI due to adenovirus-associated obstructive uropathy and necrotizing tubulointerstitial nephritis in a bone marrow transplant recipient. Bone Marrow Transplant 2003; 31: 1173–1176.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology, Dialysis and Transplantation, S. Bortolo Hospital, Viale Rodolfi 37, 36100, Vicenza, Italy

    Claudio Ronco

Authors
  1. Claudio Ronco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio Ronco .

Editor information

Editors and Affiliations

  1. Charité Campus Virchow, Universitätsklinikum Berlin, Augustenburger Platz 1, Berlin, 13353, Germany

    Achim Jörres

  2. Dipto. Nefrologia, Ospedale San Bortolo, Viale Rodolfi 16, Vicenza, 36100, Italy

    Claudio Ronco

  3. School of Medicine, University of Pittsburgh, Terrace Street 3550, Pittsburgh, 15261, U.S.A.

    John A. Kellum

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ronco, C. (2010). Acute Kidney Injury in Oncological Disorders and Tumor Lysis Syndrome. In: Jörres, A., Ronco, C., Kellum, J. (eds) Management of Acute Kidney Problems. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69441-0_41

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-69441-0_41

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-69413-7

  • Online ISBN: 978-3-540-69441-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation